搜索临床试验以:ZTI-01
总计1112个结果
-
Cassiopea SpAICON Clinical Research; Canfield Scientific Inc.; Ergomed PLC; Pharmapace Inc招聘中
-
Pfizer终止黑色素瘤 | 软组织肉瘤 | 蕈样肉芽肿 | 乳腺癌 | 实体瘤 | 鳞状细胞癌 | 人乳头瘤病毒相关恶性肿瘤 | 默克尔细胞癌美国
-
Avva Rus, JSCSt. Vladimir Moscow Children's Clinical Hospital; Arhangelsk Regional Children's Clinical Hospital...未知
-
aRigen Pharmaceuticals, Inc.未知
-
Canadian Institute of Natural and Integrative MedicineAlberta Health services; Alberta Children's Hospital; Alberta Heritage Foundation for Medical... 和其他合作者未知
-
The University of Texas Health Science Center,...North American Rescue, LLC终止
-
London School of Hygiene and Tropical MedicineBiomedical Research and Training Institute主动,不招人
-
Johns Hopkins UniversityKarolinska Institutet; Baylor College of Medicine; University of Stellenbosch尚未招聘呼吸道感染 | 缺氧 | 孩子 | 婴儿
-
Makerere UniversityHarvard Medical School (HMS and HSDM); Massachusetts General Hospital; University of Washington主动,不招人
-
Cassiopea SpAICON Clinical Research; Canfield Scientific Inc.; Ergomed PLC; Pharmapace Inc招聘中
-
Leap Therapeutics, Inc.Merck Sharp & Dohme LLC完全的
-
Mikrobiomik Healthcare Company S.L.完全的
-
Cassava Sciences, Inc.Premier Research Group plc主动,不招人
-
Egetis TherapeuticsUniversity of Edinburgh; NHS Lothian完全的
-
Riccardo SerrainoSocieta' Italiana Di Malattie Infettive E Tropicali招聘中
-
ANRS, Emerging Infectious Diseases招聘中
-
University of Zurich完全的
-
National Cancer Institute (NCI)完全的
-
Mylan Technologies Inc.Mylan Inc.主动,不招人
-
Cassava Sciences, Inc.Premier Research Group plc主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)招聘中复发性 B 细胞非霍奇金淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤,未另行说明 | 具有 MYC 和 BCL2 或 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性高级 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 复发性 3b 级滤泡性淋巴瘤 | 难治性 3b 级滤泡性淋巴瘤 | 复发性血管内大 B 细胞淋巴瘤 | 复发性 T 细胞/富含组织细胞的大 B 细胞淋巴瘤 及其他条件美国
-
VA Office of Research and DevelopmentUniversity of California, Los Angeles; University of Southern California; Center for the Advancement...邀请报名